The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 64 articles
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry
Gargiulo G,
Marenna A,
Sperandeo L,
Manzi L,
Avvedimento M,
Simonetti F,
Canonico M,
Paolillo R,
Spinelli A,
Borgia F,
Diserafino L,
Franzone A,
Stabile E,
Piccolo R,
Cirillo P,
Valgimigli M,
Esposito G
March 20, 2023 | 10.4244/EIJ-D-22-00594
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial
Ono M,
Hara H,
Kawashima H,
Gao C,
Wang R,
Wykrzykowska JJ,
Piek J,
Garg S,
Hamm C,
Steg PG,
Valgimigli M,
Windecker S,
Vranckx P,
Onuma Y,
Serruys P
August 5, 2022 | 10.4244/EIJ-D-21-00870
Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!
July 22, 2022 | 10.4244/EIJ-E-22-00004
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score
Gragnano F,
Jolly SS,
Mehta SR,
Branca M,
van Klaveren D,
Frigoli E,
Gargiulo G,
Leonardi S,
Vranckx P,
Di Maio D,
Monda E,
Fimiani L,
Fioretti V,
Chianese S,
Andò G,
Esposito G,
Sangiorgi G,
Biondi-Zoccai G,
Heg D,
Calabrò P,
Windecker S,
Romagnoli E,
Valgimigli M
December 17, 2021 | 10.4244/EIJ-D-21-00441
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition
Gragnano F,
Spirito A,
Corpataux N,
Vaisnora L,
Galea R,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Billinger M,
Hunziker L,
Stortecky S,
Pilgrim T,
Bär S,
Ueki Y,
Capodanno D,
Urban P,
Pocock S,
Mehran R,
Heg D,
Windecker S,
Räber L,
Valgimigli M
December 3, 2021 | 10.4244/EIJ-D-21-00181
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis
September 20, 2021 | 10.4244/EIJ-D-20-01197
Subcutaneous RUC-4 for acute myocardial infarction: a new treatment on the horizon for pre-hospital care?
August 6, 2021 | 10.4244/EIJV17I5A63
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions
Zimarino M,
Angiolillo D,
Dangas G,
Capodanno D,
Barbato E,
Hahn J,
Giustino G,
Watanabe H,
Costa F,
Cuisset T,
Rossini R,
Sibbing D,
Burzotta F,
Louvard Y,
Shehab A,
Renda G,
Kimura T,
Gwon H,
Chen S,
Costa R,
Koo B,
Storey R,
Valgimigli M,
Mehran R,
Stankovic G
May 16, 2021 | 10.4244/EIJ-D-20-00885
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska JJ,
de Winter RJ,
Hamm C,
Steg PG,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores
Ueki Y,
Bär S,
Losdat S,
Otsuka T,
Zanchin C,
Zanchin T,
Gragnano F,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Hunziker L,
Stortecky S,
Pilgrim T,
Heg D,
Valgimigli M,
Windecker S,
Räber L
August 28, 2020 | 10.4244/EIJ-D-20-00052
The SYNTAX score on its way out or … towards artificial intelligence: part I
Serruys P,
Chichareon P,
Modolo R,
Leaman D,
Reiber J,
Emanuelsson H,
Di Mario C,
Pijls NHJ,
Morel M,
Valgimigli M,
Farooq V,
van Klaveren D,
Capodanno D,
Andreini D,
Bourantas C,
Davies J,
Banning A,
Escaned J,
Piek J,
Echavarria-Pinto M,
Taylor C,
Thomsen B,
Collet C,
Pompilio G,
Bartorelli AL,
Glocker B,
Dressler O,
Stone G,
Onuma Y
May 20, 2020 | 10.4244/EIJ-D-19-00543A
The SYNTAX score on its way out or … towards artificial intelligence: part II
Serruys P,
Chichareon P,
Modolo R,
Leaman D,
Reiber J,
Emanuelsson H,
Di Mario C,
Pijls NHJ,
Morel M,
Valgimigli M,
Farooq V,
van Klaveren D,
Capodanno D,
Andreini D,
Bourantas C,
Davies J,
Banning A,
Escaned J,
Piek J,
Echavarria-Pinto M,
Taylor C,
Thomsen B,
Collet C,
Pompilio G,
Bartorelli AL,
Glocker B,
Dressler O,
Stone G,
Onuma Y
May 20, 2020 | 10.4244/EIJ-D-19-00543B
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial
Tomaniak M,
Chichareon P,
Modolo R,
Takahashi K,
Chang C,
Kogame N,
Spitzer E,
Buszman P,
van Geuns R,
Valkov V,
Steinwender C,
Geisler T,
Prokopczuk J,
Sabaté M,
Zmudka K,
Rademaker-Havinga T,
Tijssen J,
Jüni P,
Hamm C,
Steg PG,
Onuma Y,
Vranckx P,
Valgimigli M,
Windecker S,
Baber U,
Anderson R,
Dominici M,
Serruys P
April 3, 2020 | 10.4244/EIJ-D-19-00699
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber C,
Sabaté M,
Iqbal J,
Wykrzykowska JJ,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg PG,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial
Gargiulo G,
Pasquetto G,
Brugaletta S,
Ferrari F,
Casu G,
Guiducci V,
Dellavalle A,
Liistro F,
Mauro C,
van't Hof A,
Omerovic E,
Curello S,
de la Torre Hernandez J,
De Servi S,
Belloni F,
Windecker S,
Penzo C,
Colombo A,
da Costa B,
Frigoli E,
Palmieri C,
Nazzaro M,
Falcone C,
Liso A,
Vigna C,
Abate F,
Comeglio M,
Diletti R,
Gabrielli G,
Di Lorenzo E,
Mazzarotto P,
Zimarino M,
Moretti C,
Valgimigli M
June 12, 2019 | 10.4244/EIJ-D-18-00247
Transradial left main PCI is safe and effective
November 20, 2018 | 10.4244/EIJV14I10A192
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial
Iglesias JF,
Muller O,
Zaugg S,
Roffi M,
Kurz D,
Vuilliomenet A,
Weilenmann D,
Kaiser C,
Tapponnier M,
Heg D,
Valgimigli M,
Eeckhout E,
Jüni P,
Windecker S,
Pilgrim T
August 24, 2018 | 10.4244/EIJ-D-17-00734
Latest news
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023
AHEAD OF PRINT
Navitor CE mark cohort outcomes
FREE ARTICLE - Lars Sondergaard et al
March 9, 2023
AHEAD OF PRINT
One-year SAPIEN 3U registry results
FREE ARTICLE - Stefano Cannata et al
March 7, 2023
AHEAD OF PRINT
The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation
FREE ARTICLE - Farhang Aminfar et al
March 3, 2023